BioSpace News Archive

Scott Partridge, former vice president of global strategy for Monsanto, now part of Bayer, has been named the company’s U.S. General Counsel.

Charles River Laboratories International, Inc. today announced that it was awarded a five-year, $95.7 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), which is one of the largest institutes of the National Institutes of Health (NIH).

Additional Funding to Advance Phase 2b Development Program in OAB

Timicoin/TimiHealth and FirstVitals Health and Wellness, Inc. have entered into the development phase to use TimiHealth’s blockchain to both aggregate data across multiple electronic health records (EHRs) used by providers across the State of Hawaii and fulfill care coordination requirements of the CMS Comprehensive Primary Care Plus (CPC+) program.

Aethlon Medical, Inc. (Nasdaq:AEMD), an immunotherapeutic technology company focused on unmet needs in global health, today announced that its CEO, Jim Joyce, will present at the 2018 BIO Investor Forum on Thursday, October 18, 2018 at 3:15 p.m. Pacific Time.

IQVIA today announced that the pharmaceuticals division of Roche (F. Hoffmann-La Roche Ltd) has selected IQVIA’s commercial technology suite for deployment across more than 100 markets.

Kala Pharmaceuticals (Kala) (NASDAQ:KALA), today announced that it has submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for KPI-121 0.25%, a topical product candidate which, if approved, could be the first FDA-approved product for the temporary relief of signs and symptoms of dry eye disease.

India Globalization Capital, Inc. announces financial results for the quarter ended September 30, 2018, which is the second quarter of its 2019 fiscal year.

FOUR COMPANIES UNITE TO FORM DISCOVERY LIFE SCIENCES

Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with the goal of developing and commercializing novel solutions that address challenges in healthcare.